Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosyltransferases are a large family of enzymes (EC 2.4.x.y) responsible for transferring sugar moieties from activated donor molecules (typically nucleotide sugars) to a wide variety of acceptor molecules, forming glycosidic bonds[3][2][1]. These reactions are crucial in the biosynthesis of oligosaccharides, polysaccharides, glycoproteins, and glycolipids, impacting cell signaling, protein folding, and cell–cell interactions[3][5]. Glycosyltransferases can be categorized into numerous families based on sequence and structural features, with several well-defined 3D folds such as GT-A, GT-B, and GT-C[1][2][4]. They can act via either retaining or inverting mechanisms, influencing the stereochemistry of the sugar linkage[2][4]. Dysfunction in glycosyltransferases is implicated in a wide variety of human diseases, including cancer, immunological disorders, congenital metabolic syndromes, and infectious diseases[3]. Enzymes in this class are common drug targets, though the broad role of glycosylation creates significant therapeutic challenges relating to selectivity and toxicity[2]. Caveats: - "Glycosyltransferase enzyme family" is not a specific molecule but rather denotes a very large enzyme superfamily containing over 100 distinct human enzymes and many more in other organisms[2][3][5]. Each family or isoenzyme (e.g., glucosylceramide synthase, oligosaccharyltransferase, sialyltransferase) has unique function and targeting properties. Structured data should reference a specific isoform or gene/protein for clear therapeutic or biomarker information. - Singular "Glycosyltransferase enzyme" conforms to accepted naming conventions, while the plural "Glycosyltransferase enzyme family" is non-standard and too broad to accurately describe a discrete drug target. If you are seeking structured information for a specific glycosyltransferase (e.g., "glucosylceramide synthase" or "UDP-glucuronosyltransferase 1A1"), clarify the isoform for precise and actionable data.
Inhibition of glycosyltransferase activity; Modulation of glycosylation patterns; Substrate competition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosyltransferase enzyme (GT (or GTase)).